Anti-CD32 antibody (Clone: AT10) {Biotin}

Referência NB-22-52163-100

Tamanho : 0.1mg

Marca : Neo Biotech

Solicitar mais informações

Contactar o distribuidor local :


Telefone : +1 850 650 7790

General Info

Host: Mouse
Applications: FC
Reactivity: Human/Pig/Rhesus/Dog
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-CD32 is suitable for use in Flow Cytometry research applications.
Clonality: Monoclonal
Clone ID: AT10
Conjugation: Biotin
Isotype: IgG1
Formulation: PBS with 0.09% sodium azide and 1% BSA
Concentration: 0.1 mg/mL
Storage Instruction: Store at 2-8°C upon receipt.

Information

Gene Symbol: FCGR2A
Gene ID: 2212
Uniprot ID: FCG2A_HUMAN
Immunogen: K562 cell line.

Description

Tissue Specificity Found on monocytes, neutrophils and eosinophil platelets.
Post Translational Modifications Phosphorylated by SRC-type Tyr-kinases such as LYN, BLK, FYN, HCK and SYK.
Function Binds to the Fc region of immunoglobulins gamma. Low affinity receptor. By binding to IgG it initiates cellular responses against pathogens and soluble antigens. Promotes phagocytosis of opsonized antigens.
Protein Name Low Affinity Immunoglobulin Gamma Fc Region Receptor Ii-A
Igg Fc Receptor Ii-A
Cdw32
Fc-Gamma Rii-A
Fc-Gamma-Riia
Fcrii-A
Cd Antigen Cd32
Database Links Reactome: R-HSA-2029481
Reactome: R-HSA-2029482
Reactome: R-HSA-2029485
Reactome: R-HSA-6798695
Reactome: R-HSA-9664323
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Alternative Antibody Names Anti-Low Affinity Immunoglobulin Gamma Fc Region Receptor Ii-A antibody
Anti-Igg Fc Receptor Ii-A antibody
Anti-Cdw32 antibody
Anti-Fc-Gamma Rii-A antibody
Anti-Fc-Gamma-Riia antibody
Anti-Fcrii-A antibody
Anti-Cd Antigen Cd32 antibody
Anti-FCGR2A antibody
Anti-CD32 antibody
Anti-FCG2 antibody
Anti-FCGR2A1 antibody
Anti-IGFR2 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance